Literature DB >> 16837165

PLD2 forms a functional complex with mTOR/raptor to transduce mitogenic signals.

Sang Hoon Ha1, Do-Hyung Kim, Il-Shin Kim, Jung Hwan Kim, Mi Nam Lee, Hyun Ju Lee, Jong Heon Kim, Sung Key Jang, Pann-Ghill Suh, Sung Ho Ryu.   

Abstract

Mammalian target-of-rapamycin (mTOR), which is a master controller of cell growth, senses a mitogenic signal in part through the lipid second messenger phosphatidic acid (PA), generated by phospholipase D (PLD). To understand further which isozymes of PLD are involved in this process, we compared the effect of PLD isozymes on mTOR activation. We found that PLD2 has an essential role in mitogen-induced mTOR activation as the siRNA-mediated knockdown of PLD2, not of PLD1, profoundly reduced the phosphorylations of S6K1 and 4EBP1, well-known mTOR effectors. Furthermore, exogenous PA-induced mTOR activation was abrogated by PLD2 knockdown, but not by PLD1 knockdown. This abrogation was found to be the result of complex formation between PLD2 and mTOR/raptor. PLD2 possesses a TOS-like motif (Phe-Glu-Val-Gln-Val, a.a. 265-269), through which it interacts with raptor independently of the other TOS motif-containing proteins, S6K1 and 4EBP1. PLD2-dependent mTOR activation appears to require PLD2 binding to mTOR/raptor with lipase activity, since lipase-inactive PLD2 cannot trigger mTOR activation despite its ability to interact with mTOR/raptor. Abrogation of mitogen-dependent mTOR activation by PLD2 knockdown was rescued only by wild type PLD2, but not by raptor binding-deficient and lipase-inactive PLD2. Our results demonstrate the importance of localized PA generation for the mitogen-induced activation of mTOR, which is achieved by a specific interaction between PLD2 and mTOR/raptor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837165     DOI: 10.1016/j.cellsig.2006.05.021

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  26 in total

Review 1.  Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.

Authors:  David A Foster
Journal:  Biochim Biophys Acta       Date:  2009-03-02

2.  Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways.

Authors:  Keunwook Lee; Prathyusha Gudapati; Srdjan Dragovic; Charles Spencer; Sebastian Joyce; Nigel Killeen; Mark A Magnuson; Mark Boothby
Journal:  Immunity       Date:  2010-06-25       Impact factor: 31.745

Review 3.  Phospholipase D in brain function and Alzheimer's disease.

Authors:  Tiago Gil Oliveira; Gilbert Di Paolo
Journal:  Biochim Biophys Acta       Date:  2010-04-23

Review 4.  Mechanotransduction and the regulation of mTORC1 signaling in skeletal muscle.

Authors:  Troy A Hornberger
Journal:  Int J Biochem Cell Biol       Date:  2011-05-19       Impact factor: 5.085

5.  Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORC1).

Authors:  Limei Xu; Darin Salloum; Phil S Medlin; Mahesh Saqcena; Paige Yellen; Benjamin Perrella; David A Foster
Journal:  J Biol Chem       Date:  2011-05-28       Impact factor: 5.157

6.  Cyclic AMP controls mTOR through regulation of the dynamic interaction between Rheb and phosphodiesterase 4D.

Authors:  Hyun Wook Kim; Sang Hoon Ha; Mi Nam Lee; Elaine Huston; Do-Hyung Kim; Sung Key Jang; Pann-Ghill Suh; Miles D Houslay; Sung Ho Ryu
Journal:  Mol Cell Biol       Date:  2010-09-13       Impact factor: 4.272

Review 7.  Frontier of epilepsy research - mTOR signaling pathway.

Authors:  Chang Hoon Cho
Journal:  Exp Mol Med       Date:  2011-05-31       Impact factor: 8.718

Review 8.  Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis.

Authors:  Wenjuan Su; Qin Chen; Michael A Frohman
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

Review 9.  Key factors in mTOR regulation.

Authors:  Xiaochun Bai; Yu Jiang
Journal:  Cell Mol Life Sci       Date:  2009-10-13       Impact factor: 9.261

Review 10.  Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Authors:  Ronald C Bruntz; Craig W Lindsley; H Alex Brown
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.